A Study of Ozanimod in Pregnant Women With Ulcerative Colitis and Their Offspring

ZEPOSIA® (Ozanimod) Ulcerative Colitis Pregnancy Registry: a Prospective, Observational Study on the Safety of Ozanimod Exposure in Pregnant Women With Ulcerative Colitis and Their Offspring

The purpose of this study is to evaluate association between ozanimod exposure during pregnancy and subsequent maternal, fetal, and infant outcomes.

Inclusion Criteria:

• Currently or recently pregnant
• Diagnosis of UC
• Resident of country where ozanimod is prescribed for the treatment of UC

Exclusion Criteria:

• Exposure to other S1P therapies at any time during pregnancy

Other protocol-defined eligibility criteria apply.